Calkoen F

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.

Spanjaart AM, Ljungman P, Tridello G, ..., Kersten MJ, Mielke S

Leukemia - (-) - [2024-07-23; online 2024-07-23]

Category: Rehabilitation Type: Journal article

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.

Spanjaart AM, Ljungman P, de La Camara R, ..., Kersten MJ, Mielke S

Leukemia - (-) - [2021-11-08; online 2021-11-08]

Category: Health Type: Journal article